
Lynne V. Abruzzo MD
Clinical Cytogenetics
Professor, Pathology, Ohio State University College of Medicine
Join to view full profile
1120 15th StAugusta, GA 30912
Phone+1 706-721-8623
Fax+1 706-721-1459
Dr. Abruzzo is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of MichiganResidency, Pathology-Anatomic and Clinical, 1986 - 1990
University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 1986
Certifications & Licensure
GA State Medical License 2022 - 2027
OH State Medical License 2013 - 2027
SC State Medical License 2024 - 2027
DC State Medical License 1994 - 2014
MD State Medical License 1990 - 2014
TX State Medical License 2000 - 2014
American Board of Pathology Anatomic Pathology & Clinical Pathology
American Board of Pathology Hematology
American Board of Medical Genetics and Genomics Clinical Cytogenetics and Genomics
American Board of Medical Genetics and Genomics Laboratory Genetics and Genomics
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification ClinicStation, UT MD Anderson Cancer Center, 2013
Publications & Presentations
PubMed
- Context-dependent correlations mislead transcriptomic network inference in bulk and single-cell data.Amir Asiaee, Polina Bombina, Reginald L McGee 2nd, Jake Reed, Zachary B Abrams
Biorxiv. 2026-06-28 - WayFindR: investigating feedback in biological pathways.Polina Bombina, Reginald L McGee Ii, Jake Reed, Zachary B Abrams, Lynne V Abruzzo
NAR Genomics and Bioinformatics. 2026-06-01 - Clustering Digestive Tract Tumors Using Transcriptomic and Mutation Data.Dwayne G Tally, Polina Bombina, Jake Reed, Jeffrey Kinne, Lynne V Abruzzo
Cancers. 2026-04-30
Journal Articles
- Trisomy 12 Chronic Lymphocytic Leukemia Expresses a Unique Set of Activated and Targetable PathwaysMichael J Keating, Lynne V Abruzzo, Haematologica
Press Mentions
FCR Still an Option in IGHV-Unmutated CLL?October 8th, 2019
Deletion 20q in CLL May Represent Disease ProgressionMay 28th, 2015
Grant Support
- Validation Of RNA And DNA Biomarkers Of Prognosis In Chronic Lymphocytic LeukemiaNational Cancer Institute2006–2008
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: